CurAegis (CRGS) 10-Q 13 May 20 2020 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 13, 2020
Document Information [Line Items]
Entity Registrant Name	CurAegis Technologies, Inc.
Entity Central Index Key	0001063197
Trading Symbol	crgs
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		51,347,810
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Title of 12(g) Security	$.01 par value common voting stock

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current Assets:
Cash	$ 157,000	$ 18,000
Prepaid expenses	4,000	2,000
Total current assets	161,000	20,000
Right to use asset (net)	180,000	193,000
Property and equipment (net)	35,000	38,000
Total non-current assets	215,000	231,000
Total Assets	376,000	251,000
Current Liabilities:
Liability for inventory	1,747,000	1,764,000
Demand notes	650,000	650,000
Promissory notes	425,000	425,000
Accounts payable	412,000	420,000
Accrued interest	621,000	509,000
Current right-to-use obligation	65,000	64,000
Other current liabilities	28,000	36,000
Accrued wages and benefits	52,000	50,000
Total current liabilities	4,000,000	3,918,000
Non-current right-to-use obligation	112,000	126,000
Senior convertible notes (net)	9,154,000	8,410,000
Total Liabilities	13,266,000	12,454,000
Commitments and other matters
Stockholders' Deficiency:
Common stock, $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at March 31, 2020 and December 31, 2019: 51,187,236 and 50,979,964 respectively	512,000	510,000
Additional paid-in capital	78,336,000	78,272,000
Accumulated deficit	(92,178,000)	(91,425,000)
Total Stockholders' Deficiency	(12,890,000)	(12,203,000)
Total Liabilities and Stockholders' Deficiency	376,000	251,000
Preferred Class C [Member]
Stockholders' Deficiency:
Preferred stock, value	157,000	157,000
Series C2 Preferred Stock [Member]
Stockholders' Deficiency:
Preferred stock, value	245,000	245,000
Series C3 Preferred Stock [Member]
Stockholders' Deficiency:
Preferred stock, value	32,000	32,000
Preferred Class A [Member]
Stockholders' Deficiency:
Preferred stock, value	5,000	5,000
Preferred Class B [Member]
Stockholders' Deficiency:
Preferred stock, value	$ 1,000	$ 1,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	51,187,236	50,979,964
Common stock, shares outstanding (in shares)	51,187,236	50,979,964
Preferred Class C [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	15,687,500	15,687,500
Preferred stock, shares outstanding (in shares)	15,687,500	15,687,500
Series C2 Preferred Stock [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	24,500,000	24,500,000
Preferred stock, shares outstanding (in shares)	24,500,000	24,500,000
Series C3 Preferred Stock [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	3,238,000	3,238,000
Preferred stock, shares outstanding (in shares)	3,238,000	3,238,000
Preferred Class A [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0.40	$ 0.40
Preferred stock, shares issued (in shares)	468,221	468,221
Preferred stock, shares outstanding (in shares)	468,221	468,221
Preferred Class B [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0.50	$ 0.50
Preferred stock, shares issued (in shares)	67,500	67,500
Preferred stock, shares outstanding (in shares)	67,500	67,500

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue and Cost of revenue:
CURA revenue	$ 3,000	$ 7,000
Cost of revenue	1,000	6,000
Margin	2,000	1,000
Costs and expenses:
Recovery on inventory reserve	(16,000)
Engineering and development	91,000	331,000
General and administrative	343,000	544,000
Total costs and expenses	418,000	875,000
Loss from operations	(416,000)	(874,000)
Non-operating expense:
Interest expense	(337,000)	(274,000)
Non-operating expense	(337,000)	(274,000)
Loss before income taxes	(753,000)	(1,148,000)
Income taxes
Net loss	(753,000)	(1,148,000)
Preferred stock dividends	54,000	54,000
Net loss attributable to common stockholders	$ (807,000)	$ (1,202,000)
Net loss per share attributable to common stockholders
Basic and Diluted (in dollars per share)	$ (0.02)	$ (0.02)
Weighted average number of shares of common stock
Basic and Diluted (in shares)	51,148,000	50,401,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member]Series C Preferred Stock [Member]	Preferred Stock [Member]Series C2 Preferred Stock [Member]	Preferred Stock [Member]Series C3 Preferred Stock [Member]	Preferred Stock [Member]Preferred Class A [Member]	Preferred Stock [Member]Preferred Class B [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at December 31, 2019 (in shares) at Dec. 31, 2018	15,687,500	24,500,000	3,268,000	468,221	67,500	50,364,549
Balance at December 31, 2019 at Dec. 31, 2018	$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000	$ 504,000	$ 77,725,000	$ (87,149,000)	$ (8,479,000)
Stock-based compensation							59,000		59,000
Common shares issued for interest (in shares)						35,996
Common shares issued for interest							8,000		8,000
Net Loss								(1,148,000)	(1,148,000)
Stock-based compensation							59,000		59,000
Warrants issued with convertible note							63,000		63,000
Balance at March 31, 2020 (in shares) at Mar. 31, 2019	15,687,500	24,500,000	3,268,000	468,221	67,500	50,400,545
Balance at March 31, 2020 at Mar. 31, 2019	$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000	$ 504,000	77,855,000	(88,297,000)	(9,497,000)
Balance at December 31, 2019 (in shares) at Dec. 31, 2019	15,687,500	24,500,000	3,238,000	468,221	67,500	50,979,964
Balance at December 31, 2019 at Dec. 31, 2019	$ 157,000	$ 245,000	$ 32,000	$ 5,000	$ 1,000	$ 510,000	78,272,000	(91,425,000)	(12,203,000)
Stock-based compensation							39,000		39,000
Common shares issued for interest (in shares)						94,772
Common shares issued for interest						$ 1,000	16,000		17,000
Common shares issued (in shares)						112,500
Common shares issued						$ 1,000	9,000		10,000
Net Loss								(753,000)	(753,000)
Stock-based compensation							39,000		39,000
Balance at March 31, 2020 (in shares) at Mar. 31, 2020	15,687,500	24,500,000	3,238,000	468,221	67,500	51,187,236
Balance at March 31, 2020 at Mar. 31, 2020	$ 157,000	$ 245,000	$ 32,000	$ 5,000	$ 1,000	$ 512,000	$ 78,336,000	$ (92,178,000)	$ (12,890,000)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (753,000)	$ (1,148,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount reported as interest	200,000	165,000
Depreciation and amortization	19,000	30,000
Stock-based compensation	39,000	59,000
Interest paid in shares	(17,000)
Fair market value common shares issued with debt		9,000
Changes in working capital items:
Prepaid expenses	(2,000)	12,000
Liability for inventory	(17,000)
Accounts payable	(8,000)	212,000
Accrued interest	121,000	53,000
Other current liabilities	(5,000)	5,000
Accrued wages and benefits	2,000	26,000
Net cash used in operating activities	(421,000)	(577,000)
Cash flows from financing activities:
Proceeds from issuance of senior convertible notes (net)	560,000	450,000
Proceeds from issuance of unsecured promissory notes		125,000
Net cash provided by financing activities	560,000	575,000
Net increase (decrease) in cash	139,000	(2,000)
Cash at January 1	18,000	53,000
Cash at March 31	157,000	51,000
Supplemental Disclosures:
Cash used for payment of interest expense	7,000	47,000
Debt discount related to issuance of convertible notes	16,000	63,000
Common shares issued in payment of interest expense	$ 17,000	$ 8,000

Note 1 - The Company and Basis

Note 1 - The Company and Basis of Presentation	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 CurAegis Technologies, Inc. (“CurAegis”, “the Company”) was incorporated as a New York business corporation in September 1996 2016 two The Company is focused on the commercialization of a wellness and safety system (the CURA System) and a uniquely designed hydraulic pump that will be smaller, lighter, less expensive and more efficient than current technology. The Company has not The Company has created the CURA app to offer products that reduce fatigue risk in the workplace and help individuals manage their sleep and improve alertness. The CURA System consists of a real-time alertness measurement and the Z-Coach wellness program. The Aegis hydraulic pump technology brings to the hydraulic industry a unique technology that is: smaller, lighter and less expensive, is more efficient and as reliable as conventional pumps and motors. During 2019, April 8, 2020, 19 It is important to note that the cycle time from the initiation of the sales process to revenue realization can be highly variable especially as a start-up entity. In addition to the activities to be undertaken to implement our plan of operations, we may Current Cash Outlook and Management Plans As of March 31, 2020, $157,000, $3,839,000, $92,178,000 $12,890,000. three March 31, 2020 $560,000 Management estimates that the 2020 $1.7 $2 three March 31, 2020. March 31, 2020, not Since inception, we have financed our operations by the sale of our securities and debt financings. We need to raise additional funds to meet our working capital needs, to fund expansion of our business, to complete development, testing and marketing of our products, or to make strategic acquisitions or investments. No may not The Company’s ability to fund its current and future commitments from its available cash depends on its ability to launch and generate sales from the CURA app. If the Company cannot generate revenue from the CURA app, it would need to raise funds in order to meet its working capital needs and pursue its growth strategy. Although there can be no

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 2 Basis of Presentation: 10 8 03 X not not December 31, 2019 2019 10 Consolidation: 56% March 31, 2020, Use of Estimates: Reclassifications: may Cash: may $5,000. Inventory March 31, 2020 December 31, 2019 Depreciation and amortization: three March 31, 2020 2019 For Three Months ended March 31, 2020 2019 Amortization right-to-use asset $ 16,000 $ 19,000 Software - 4,000 Property and equipment 3,000 7,000 $ 19,000 $ 30,000 Right to use building asset: No. 2016 02, January 1, 2019. not no Software, Property and Equipment: 3 5 7 Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may Fair Value of Financial Instruments: , one three Level 1: Level 2: Level 3: not The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 March 31, 2020 December 31, 2019. $4,668,000 March 31, 2020 March 31, 2020. Revenue Recognition and Deferred Revenue: 606, The Company's net revenue is derived primarily from domestic customers. For the three March 31, 2020 $3,000. 100% three March 31, 2020. 30 CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the Company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach program provides fatigue training over an annual subscription period of twelve Engineering and Development and Patents: three March 31, 2020 2019 $3,000 $10,000 Stock-based Compensation: 718 10 718 10. No The Company recognizes stock compensation expense in accordance with FASB ASU 2019 07, 718 20 Income Taxes: not not We account for uncertain tax positions using a more-likely-than- not not not March 31, 2020, December 31, 2019, no Loss per Common Share: 260 10 March 31, 2020 2019, 110,877,833 96,927,383 625,000 March 31, 2020 2019 not

Note 3 - Inventory and Vendor L

Note 3 - Inventory and Vendor Liability	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 3 March 31, 2020 December 31, 2019 Raw materials $ 1,648,000 $ 1,665,000 Finished goods 69,000 69,000 1,717,000 1,734,000 Less: Reserve (1,717,000 ) (1,734,000 ) Inventory (net) $ - $ - Liability for inventory $ 1,747,000 $ 1,764,000 During 2017, third During the three March 31, 2020, $16,000

Note 4 - Demand Note

Note 4 - Demand Note	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Long-term Debt [Text Block]	NOTE 4 On July 23, 2019, $1,500,000 The co-borrowers participating in this credit facility received 30,000 $100,000 one one $0.15 five As of March 31, 2020, $650,000 195,000 $21,000 4,333,333 $0.15 $276,000 Advances drawn under this facility have been issued as demand notes with an adjustable interest rate set at the bank’s prime rate, which was 3.25% March 31, 2020. $7,000 three March 31, 2020. The common shares issued with these demand notes are being offered and sold in a private placement exempt from registration under Section 4 2 1933 506 not may not

Note 5 - Senior Convertible Not

Note 5 - Senior Convertible Notes	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 5 At March 31, 2020, $10,870,000 $1,716,000, $9,154,000. December 31, 2019, $10,310,000 $1,990,000 $8,410,000. During the first 2020, 2019 not twelve Scheduled maturities on the Company’s convertible notes is as follows: $2,990,000 twelve December 31, 2021, $2,775,000 twelve December 31, 2022; $3,395,000 twelve December 31, 2023 $1,710,000 Included in the face value of convertible notes outstanding at March 31, 2020 December 31, 2019, $2,363,000 $2,477,000 $1,670,000 $1,170,000 March 31, 2020 December 31, 2019, Total 2019 6% Notes JULY 2018 Notes 2018 Notes 2017 6% Notes 2016 6% Notes Face value December 31, 2019 $ 10,310,000 $ 650,000 $ 1,675,000 $ 625,000 $ 4,370,000 $ 2,990,000 Notes issued 560,000 560,000 - - - - Face value March 31, 2020 $ 10,870,000 $ 1,210,000 $ 1,675,000 $ 625,000 $ 4,370,000 $ 2,990,000 Debt discount December 31, 2019 $ (1,900,000 ) $ (3,000 ) $ (353,000 ) $ (185,000 ) $ (362,000 ) $ (997,000 ) Debt discount issued (16,000 ) (16,000 ) - - - - Amortization reported as interest 200,000 8,000 20,000 11,000 28,000 133,000 Debt discount March 31, 2020 $ (1,716,000 ) $ (11,000 ) $ (333,000 ) $ (174,000 ) $ (334,000 ) $ (864,000 ) Senior Convertible Notes (net) $ 9,154,000 $ 1,199,000 $ 1,342,000 $ 451,000 $ 4,036,000 $ 2,126,000 2019 In April 2019, $2.5 6% “2019 May 28, 2019 “2019 2019 five five The conversion rate of the notes is fixed at the greater of: $0.15 30,000 $100,000 2019 4 2 1933 506 501 During the three March 31, 2020, $560,000 $16,000 three March 31, 2020, $22,000 JULY 201 8 Convertible Notes In July 2018, $2.5 “JULY 2018 July 24, 2018 “JULY 2018 JULY 2018 five April 2019, The conversion rate of the notes was fixed at $0.25 July 24, 2018. 10% 25% $0.25 ten 4 2 1933 506 501 During the three March 31, 2020 March 31,2019, $20,000 $13,000 2018 In May 2018, $1 “2018 May 8, 2018 “2018 2018 five July 19, 2018, The conversion rate of the notes was fixed at $0.25 May 8, 2018. 10% 25% $0.25 ten 4 2 1933 506 501 During the three March 31, 2020 March 31, 2019, $12,000 $11,000 2017 The board of directors authorized the issuance of up to $5 6% “2017 May 31, 2017 “2017 2017 five 6%. 10% 25% The conversion rate of the 2017 $0.50 November 2018 $0.333 2017 November 2019 $0.333 2017 4 2 506 501 During the three March 31, 2020 March 31, 2019 $92,000 $80,000, 2016 During 2016, $3 6% “2016 August 25, 2016 “2016 2016 five August 2021 December 2021 6%. The conversion rate of the notes was fixed at $0.25 August 25, 2016. 10% $0.25 ten 4 2 1934, 506 501 1933. During the three March 31, 2020 March 31, 2019 $177,000 $169,000,

Note 6 - Unsecured Subordinated

Note 6 - Unsecured Subordinated Promissory Notes	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Short-term Debt [Text Block]	NOTE 6 The Company had $425,000 March 31, 2020 December 31, 2019. 6% June 30, 2020. three March 31, 2020 March 31, 2019, $6,000 $1,000, $21,000 $15,000 March 31, 2020 December 31, 2019,

Note 7 - Right to Use Building

Note 7 - Right to Use Building Asset	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	NOTE 7 The FASB issued ASU No. 2016 02, January 1, 2019. January 1, 2019, not no Upon adoption, the Company determined the present value of future lease costs at $257,000, 6% not September 1, 2019, not three March 31, 2019 $19,000. On August 1, 2019, 350 $212,000. 6% not December 30, 2022. three March 31, 2020 $16,000 $49,000 2020; $65,000 2021 $64,000 2022. $195,000 $18,000.

Note 8 - Software

Note 8 - Software	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Research, Development, and Computer Software Disclosure [Text Block]	NOTE 8 Investments in software for the CURA system have been amortized over an estimated useful life of 3 December 31, 2019. $4,000 three March 31, 2019.

Note 9 - Property and Equipment

Note 9 - Property and Equipment	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 9 At March 31, 2020 December 31, 2019 March 31, 2020 December 31, 2019 Office equipment $ 199,000 $ 199,000 Shop equipment 132,000 132,000 Property and equipment (gross) 331,000 331,000 Less accumulated depreciation (296,000 ) (293,000 ) Net property and equipment $ 35,000 $ 38,000

Note 10 - Business Segments

Note 10 - Business Segments	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	NOTE 10 The Company has two Segment information for the three ed March 31, 2020 for the Company’s business segments follows: CURA Aegis Corporate Total Revenue $ 3,000 $ - $ - $ 3,000 Margin 2,000 - - 2,000 Total costs and expenses 54,000 65,000 299,000 418,000 Loss from operations (52,000 ) (65,000 ) (299,000 ) (416,000 ) Non-operating expense - - (337,000 ) (337,000 ) Net loss $ (52,000 ) $ (65,000 ) $ (636,000 ) $ (753,000 ) Stock-based compensation $ 23,000 $ 4,000 $ 12,000 $ 39,000 Depreciation and amortization $ - $ 3,000 $ 16,000 $ 19,000 Assets at March 31, 2020 $ - $ 34,000 $ 181,000 $ 376,000 Segment information for the three months end ed March 31, 20 19 for the Company’s business segments follows: CURA Aegis Corporate Total Revenue $ 7,000 $ - $ - $ 7,000 Margin 1,000 - - 1,000 Total costs and expenses 339,000 169,000 367,000 875,000 Loss from operations (338,000 ) (169,000 ) (367,000 ) (874,000 ) Non-operating expense - - (274,000 ) (274,000 ) Net loss $ (338,000 ) $ (169,000 ) $ (641,000 ) $ (1,148,000 ) Stock-based compensation $ 8,000 $ 8,000 $ 43,000 $ 59,000 Depreciation and amortization $ 6,000 $ 5,000 $ 19,000 $ 30,000 Assets at March 31, 2019 $ 9,000 $ 50,000 $ 296,000 $ 355,000

Note 11 - Preferred and Common

Note 11 - Preferred and Common Stock	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 11 Common Stock We have authorized 400,000,000 $0.01 During the three March 31, 2020 94,772 $0.25 2016 2017 112,500 2019 three March 31, 2019 35,996 $0.25 2016 2017 Preferred Stock Our certificate of incorporation permits the Company to issue up to 100,000,000 $.01 Class A Preferred Stock At March 31, 2020 December 31, 2019 468,221 8,709 no 459,512 $2,759.000 March 31, 2020 $2,713,000 December 31, 2019. In the event of a liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred stockholders, Class A Preferred stockholders and Class B stockholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred stockholders’ liquidation preference was $2,759,000 $2,713,000 March 31, 2020 December 31, 2019, 1 $4.00 Class B Preferred Stock At March 31, 2020 December 31, 2019, 67,500 $496,000 March 31, 2020 $488,000 December 31, 2019. In the event of liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred stockholders, our Class A Preferred stockholders and our Class B Preferred stockholders have a liquidation preference with respect to all accumulated and unsettled dividends. In the event of a liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class B Preferred are payable in Class B Preferred shares at a rate of 1 $5.00 Series C Preferred Stock At March 31, 2020 December 31, 2019, 15,687,500 $ 6,275,000 March 31, 2020 December 31, 2019. The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 The Series C Preferred shares have no no Series C- 2 Preferred Stock At March 31, 2020 December 31, 2019, 24,500,000 2 2 $ 4,900,000 March 31, 2020 December 31, 2019. The Series C- 2 not no 2 may not, two 2 2 2 2 2 2 2 2 not Series C- 3 Preferred Stock At March 31, 2020 December 31, 2019, 3,238,000 3

Note 12 - Stock Options

Note 12 - Stock Options	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Share-based Payment Arrangement [Text Block]	NOTE 12 2016 Stock Option Plan 2016 “2016 3,000,000 may 2016 March 31, 2020, 111,250 2016 2011 Stock Option Plan 2011 “2011 3,000,000 may 2011 March 31, 2020, 352,500 2011 Under the 2016 2011 may may may not 10% may not 110% ten 10% may not five During the three March 31, 2020 2,100,000 No three March 31, 2019. Summary three March 31, 2020 March 31, 2019, $39,000 $59,000, March 31, 2020, $234,000 1 The weighted average grant date fair value of stock options issued during the three March 31, 2020 $0.10 three March 31, 2020 March 31, 2019 $42,000 $4,000, The fair value of each option granted was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: 2020 2019 Expected term (years) 6.3 - Expected forfeiture rate 0% - Risk-free rate 1.3% - Volatility 179% - Dividend yield 0.0% - The average risk-free interest rate is based on the U.S. treasury security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected life was generally determined using the simplified method as we do not The following summarizes the activity of our outstanding stock options for the three March 31, 2020: Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term (years) Value Outstanding at January 1, 2020 10,740,500 $ 0.50 2.6 $ - Granted 2,100,000 .10 Exercised - - Canceled or expired (404,250 ) .68 Outstanding at March 31, 2020 12,436,250 $ 0.43 3.5 $ 21,000 Exercisable at March 31, 2020 7,608,250 $ 0.53 2.4 $ 5,000 During the three March 31, 2020, 404,250 no no three March 31, 2019, no no March 31, 2020, $.07 $1.58

Note 13 - Warrants

Note 13 - Warrants	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Stockholders Equity Note Warrants Or Rights [Text Block]	NOTE 13 The following summarizes the activity of our outstanding warrants for the three March 31, 2020: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2020 7,731,707 0.45 (A) 6.2 (B) $ 33,000 Granted - - Exercised - - Canceled or expired (100,000 ) 2.50 Outstanding at March 31, 2020 7,631,707 0.42 (A) 6.1 (B) $ 41,000 Exercisable at March 31, 2020 7,006,707 $ 0.46 6.1 (C) $ 40,000 (A) The weighted average exercise price for warrants outstanding as of March 31, 2020 2019 1,750,000 no (B) The weighted average remaining contractual term for warrants outstanding as of March 31, 2020 2019 743,500 no (C) The weighted average remaining contractual term for warrants exercisable as of March 31, 2020, 2019 118,500 no

Note 14 - Related Party Transac

Note 14 - Related Party Transactions	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 14 As of March 31, 2020, December 31, 2019, $2,363,000 $2,477,000, 9,071,562 March 31, 2020 9,388,378 December 31, 2019. 1,184,273 1,239,288 March 31, 2020 December 31, 2019. $161,000 $164,000 March 31, 2020 December 31, 2019, As of March 31, 2020 December 31, 2019, $1,670,000 $1,170,000, 8,013,333 March 31, 2020 4,680,000 December 31, 2019. 468,000 March 31, 2020 December 31, 2019. $109,000 $88,000, March 31, 2020 December 31, 2019. As of March 31, 2020 December 31, 2019, $ 425,000 March 31, 2020, $20,000 6% June 30, 2020.

Note 15 - Subsequent Events

Note 15 - Subsequent Events	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 15 Payche ck Protection Program On April 20, 2020 $227,700 eight 1% 6 18 Common Shares Issued in Payment of Interest Expense Subsequent to March 31, 2020, 123,074 $21,000 Shares issued in Connection with 2019 Subsequent to March 31, 2020, 37,500 2019

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation: 10 8 03 X not not December 31, 2019 2019 10
Consolidation, Policy [Policy Text Block]	Consolidation: 56% March 31, 2020,
Use of Estimates, Policy [Policy Text Block]	Use of Estimates:
Reclassification, Comparability Adjustment [Policy Text Block]	Reclassifications: may
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash: may $5,000.
Inventory, Policy [Policy Text Block]	Inventory March 31, 2020 December 31, 2019
Depreciation, Depletion, and Amortization [Policy Text Block]	Depreciation and amortization: three March 31, 2020 2019 For Three Months ended March 31, 2020 2019 Amortization right-to-use asset $ 16,000 $ 19,000 Software - 4,000 Property and equipment 3,000 7,000 $ 19,000 $ 30,000
Lessee, Leases [Policy Text Block]	Right to use building asset: No. 2016 02, January 1, 2019. not no
Software Property And Equipment [Policy Text Block]	Software, Property and Equipment: 3 5 7 Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may
Fair Value Measurement, Policy [Policy Text Block]	Fair Value of Financial Instruments: , one three Level 1: Level 2: Level 3: not The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 March 31, 2020 December 31, 2019. $4,668,000 March 31, 2020 March 31, 2020.
Revenue [Policy Text Block]	Revenue Recognition and Deferred Revenue: 606, The Company's net revenue is derived primarily from domestic customers. For the three March 31, 2020 $3,000. 100% three March 31, 2020. 30 CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the Company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach program provides fatigue training over an annual subscription period of twelve
In Process Research and Development, Policy [Policy Text Block]	Engineering and Development and Patents: three March 31, 2020 2019 $3,000 $10,000
Share-based Payment Arrangement [Policy Text Block]	Stock-based Compensation: 718 10 718 10. No The Company recognizes stock compensation expense in accordance with FASB ASU 2019 07, 718 20
Income Tax, Policy [Policy Text Block]	Income Taxes: not not We account for uncertain tax positions using a more-likely-than- not not not March 31, 2020, December 31, 2019, no
Earnings Per Share, Policy [Policy Text Block]	Loss per Common Share: 260 10 March 31, 2020 2019, 110,877,833 96,927,383 625,000 March 31, 2020 2019 not

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Depreciation and Amortization [Table Text Block]	For Three Months ended March 31, 2020 2019 Amortization right-to-use asset $ 16,000 $ 19,000 Software - 4,000 Property and equipment 3,000 7,000 $ 19,000 $ 30,000

Note 3 - Inventory and Vendor_2

Note 3 - Inventory and Vendor Liability (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Schedule of Inventory, Current [Table Text Block]	March 31, 2020 December 31, 2019 Raw materials $ 1,648,000 $ 1,665,000 Finished goods 69,000 69,000 1,717,000 1,734,000 Less: Reserve (1,717,000 ) (1,734,000 ) Inventory (net) $ - $ - Liability for inventory $ 1,747,000 $ 1,764,000

Note 5 - Senior Convertible N_2

Note 5 - Senior Convertible Notes (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Convertible Debt [Table Text Block]	Total 2019 6% Notes JULY 2018 Notes 2018 Notes 2017 6% Notes 2016 6% Notes Face value December 31, 2019 $ 10,310,000 $ 650,000 $ 1,675,000 $ 625,000 $ 4,370,000 $ 2,990,000 Notes issued 560,000 560,000 - - - - Face value March 31, 2020 $ 10,870,000 $ 1,210,000 $ 1,675,000 $ 625,000 $ 4,370,000 $ 2,990,000 Debt discount December 31, 2019 $ (1,900,000 ) $ (3,000 ) $ (353,000 ) $ (185,000 ) $ (362,000 ) $ (997,000 ) Debt discount issued (16,000 ) (16,000 ) - - - - Amortization reported as interest 200,000 8,000 20,000 11,000 28,000 133,000 Debt discount March 31, 2020 $ (1,716,000 ) $ (11,000 ) $ (333,000 ) $ (174,000 ) $ (334,000 ) $ (864,000 ) Senior Convertible Notes (net) $ 9,154,000 $ 1,199,000 $ 1,342,000 $ 451,000 $ 4,036,000 $ 2,126,000

Note 9 - Property and Equipme_2

Note 9 - Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Property, Plant and Equipment [Table Text Block]	March 31, 2020 December 31, 2019 Office equipment $ 199,000 $ 199,000 Shop equipment 132,000 132,000 Property and equipment (gross) 331,000 331,000 Less accumulated depreciation (296,000 ) (293,000 ) Net property and equipment $ 35,000 $ 38,000

Note 10 - Business Segments (Ta

Note 10 - Business Segments (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	CURA Aegis Corporate Total Revenue $ 3,000 $ - $ - $ 3,000 Margin 2,000 - - 2,000 Total costs and expenses 54,000 65,000 299,000 418,000 Loss from operations (52,000 ) (65,000 ) (299,000 ) (416,000 ) Non-operating expense - - (337,000 ) (337,000 ) Net loss $ (52,000 ) $ (65,000 ) $ (636,000 ) $ (753,000 ) Stock-based compensation $ 23,000 $ 4,000 $ 12,000 $ 39,000 Depreciation and amortization $ - $ 3,000 $ 16,000 $ 19,000 Assets at March 31, 2020 $ - $ 34,000 $ 181,000 $ 376,000 CURA Aegis Corporate Total Revenue $ 7,000 $ - $ - $ 7,000 Margin 1,000 - - 1,000 Total costs and expenses 339,000 169,000 367,000 875,000 Loss from operations (338,000 ) (169,000 ) (367,000 ) (874,000 ) Non-operating expense - - (274,000 ) (274,000 ) Net loss $ (338,000 ) $ (169,000 ) $ (641,000 ) $ (1,148,000 ) Stock-based compensation $ 8,000 $ 8,000 $ 43,000 $ 59,000 Depreciation and amortization $ 6,000 $ 5,000 $ 19,000 $ 30,000 Assets at March 31, 2019 $ 9,000 $ 50,000 $ 296,000 $ 355,000

Note 12 - Stock Options (Tables

Note 12 - Stock Options (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	2020 2019 Expected term (years) 6.3 - Expected forfeiture rate 0% - Risk-free rate 1.3% - Volatility 179% - Dividend yield 0.0% -
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term (years) Value Outstanding at January 1, 2020 10,740,500 $ 0.50 2.6 $ - Granted 2,100,000 .10 Exercised - - Canceled or expired (404,250 ) .68 Outstanding at March 31, 2020 12,436,250 $ 0.43 3.5 $ 21,000 Exercisable at March 31, 2020 7,608,250 $ 0.53 2.4 $ 5,000

Note 13 - Warrants (Tables)

Note 13 - Warrants (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2020 7,731,707 0.45 (A) 6.2 (B) $ 33,000 Granted - - Exercised - - Canceled or expired (100,000 ) 2.50 Outstanding at March 31, 2020 7,631,707 0.42 (A) 6.1 (B) $ 41,000 Exercisable at March 31, 2020 7,006,707 $ 0.46 6.1 (C) $ 40,000

Note 1 - The Company and Basi_2

Note 1 - The Company and Basis of Presentation (Details Textual)	3 Months Ended	12 Months Ended
	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Number of Operating Segments	2	2
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 157,000	$ 18,000	$ 51,000	$ 53,000
Working Capital	3,839,000
Retained Earnings (Accumulated Deficit), Ending Balance	(92,178,000)	(91,425,000)
Stockholders' Equity Attributable to Parent, Ending Balance	(12,890,000)	$ (12,203,000)	$ (9,497,000)	$ (8,479,000)
Proceeds From Convertible Debt, Gross	560,000
Minimum [Member]
Cash Needed During the Year to Fund Current and Future Commitments	1,700,000
Maximum [Member]
Cash Needed During the Year to Fund Current and Future Commitments	$ 2,000,000

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Revenue from Contract with Customer, Including Assessed Tax	$ 3,000	$ 7,000
Patent Cost	3,000	$ 10,000
Excess Tax Benefit from Share-based Compensation, Operating Activities	0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total	$ 0		$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	110,877,833	96,927,383
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	625,000	625,000
Z-Coach Aviation Wellness Program Annual Subscription [Member]
Deferred Revenue Arrangement, Subscription Period (Month)			1 year
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]
Concentration Risk, Percentage	100.00%
Transferred over Time [Member]
Revenue from Contract with Customer, Including Assessed Tax	$ 3,000
Senior Convertible Promissory Notes [Member]
Long-term Debt, Fair Value	$ 4,668,000
Minimum [Member]
Property, Plant and Equipment, Useful Life (Year)	5 years
Maximum [Member]
Property, Plant and Equipment, Useful Life (Year)	7 years
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	3 years		3 years
Commercial Paper [Member] | Collateral Pledged [Member]
Debt Instrument, Collateral Amount	$ 5,000
Subsidiaries [Member]
Equity Method Investment, Ownership Percentage	56.00%

Note 2 - Summary of Significa_4

Note 2 - Summary of Significant Accounting Policies - Depreciation and Amortization (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Depreciation and amortization	$ 19,000	$ 30,000
Right-to-use Building [Member]
Depreciation and amortization	16,000	19,000
Software Development [Member]
Depreciation and amortization		4,000
Property and Equipment [Member]
Depreciation and amortization	$ 3,000	$ 7,000

Note 3 - Inventory and Vendor_3

Note 3 - Inventory and Vendor Liability (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Inventory (Recovery) Write-down	$ (16,000)

Note 3 - Inventory and Related

Note 3 - Inventory and Related Vendor Liability - Inventory (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Raw materials	$ 1,648,000	$ 1,665,000
Finished goods	69,000	69,000
Inventory, Gross, Total	1,717,000	1,734,000
Less: Reserve	(1,717,000)	(1,734,000)
Inventory (net)
Liability for inventory	$ 1,747,000	$ 1,764,000

Note 4 - Demand Note (Details T

Note 4 - Demand Note (Details Textual)	Jul. 23, 2019USD ($)$ / shares	Mar. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2019USD ($)
Long-term Debt, Gross		$ 10,870,000	$ 10,310,000
Stock Issued During Period, Value, New Issues		10,000
Credit Facility with Co-borrowers [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,500,000
Debt Instrument, Convertible, Number of Equity Instruments	30,000
Debt Instrument, Convertible, Threshold Amount Needed to Invest to Convert a Specified Number of Equity Instruments	$ 100,000
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares	$ 0.15
Debt Instrument, Term, Number of Days after Substantial Sale of Aegis Division (Day)	5 days
Long-term Debt, Gross		$ 650,000
Stock Issued in Connection with Debt Issuance, Shares (in shares) | shares		195,000
Stock Issued During Period, Value, New Issues		$ 21,000
Debt Issuance Costs, Net, Total		$ 7,000
Credit Facility with Co-borrowers [Member] | Prime Rate [Member]
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate		3.25%
Credit Facility with Co-borrowers [Member] | Rights Related to Credit Facility with Co-borrowers [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares		4,333,333
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares		$ 0.15
Warrants and Rights Outstanding		$ 276,000

Note 5 - Senior Convertible N_3

Note 5 - Senior Convertible Notes (Details Textual)	Jul. 24, 2018USD ($)$ / shares	May 08, 2018USD ($)$ / shares	Aug. 25, 2016USD ($)$ / shares	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)$ / shares	Nov. 30, 2018$ / shares	May 31, 2017$ / shares
Long-term Debt, Gross				$ 10,870,000		$ 10,310,000
Debt Instrument, Unamortized Discount, Total				1,716,000		1,900,000
Long-term Debt, Total				9,154,000
Proceeds from Convertible Debt				560,000
Increase in Unamortized Debt Discount Due to Issuance				16,000
Interest Expense, Total				337,000	$ 274,000
Warrants Related to the 2017 Convertible Notes [Member]
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold								10.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares							$ 0.333
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes								25.00%
Warrants Related to the 2016 Convertible Notes [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares			$ 0.25
Warrants and Rights Outstanding, Term (Year)			10 years
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes			10.00%
Convertible Notes [Member]
Long-term Debt, Gross				10,870,000		10,310,000
Debt Instrument, Unamortized Discount, Total				1,716,000		1,990,000
Long-term Debt, Total				9,154,000		8,410,000
Long-term Debt, Maturities, Repayments of Principal in Year Two				2,990,000
Long-term Debt, Maturities, Repayments of Principal in Year Three				2,775,000
Long-term Debt, Maturities, Repayments of Principal in Year Four				3,395,000
Long-Term Debt, Maturity, Year Four				1,710,000
Convertible Notes [Member] | Investor [Member]
Long-term Debt, Total				2,363,000		2,477,000
Convertible Notes [Member] | Affiliated Entity [Member]
Long-term Debt, Total				$ 1,670,000		$ 1,170,000
Debt Instrument, Convertible, Number of Equity Instruments				8,013,333		4,680,000
The 2019 Convertible Notes [Member]
Long-term Debt, Gross				$ 1,210,000		$ 650,000
Debt Instrument, Unamortized Discount, Total				11,000		3,000
Long-term Debt, Total				1,199,000
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement						$ 2,500,000
Debt Instrument, Interest Rate, Stated Percentage						6.00%
Debt Instrument, Term, Number of Days after Substantial Sale of Aegis Division (Day)						5 days
Debt Instrument, Term (Year)						5 years
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares						$ 0.15
Debt Instrument, Convertible, Number of Equity Instruments						30,000
Debt Instrument, Convertible, Threshold Amount Needed to Invest to Convert a Specified Number of Equity Instruments						$ 100,000
Proceeds from Convertible Debt				560,000
Increase in Unamortized Debt Discount Due to Issuance				16,000
Interest Expense, Total				22,000
July 2018 Convertible Notes [Member]
Long-term Debt, Gross				1,675,000		1,675,000
Debt Instrument, Unamortized Discount, Total				333,000		353,000
Long-term Debt, Total				1,342,000
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement	$ 2,500,000
Debt Instrument, Term (Year)	5 years
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares	$ 0.25
Proceeds from Convertible Debt
Increase in Unamortized Debt Discount Due to Issuance
Interest Expense, Total				20,000	13,000
Warrants Related to July 2018 Convertible Notes [Member]
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold	10.00%
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold	25.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares	$ 0.25
Warrants and Rights Outstanding, Term (Year)	10 years
The 2018 Convertible Notes [Member]
Long-term Debt, Gross				625,000		625,000
Debt Instrument, Unamortized Discount, Total				174,000		185,000
Long-term Debt, Total				451,000
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement		$ 1,000,000
Debt Instrument, Term (Year)		5 years
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares		$ 0.25
Proceeds from Convertible Debt
Increase in Unamortized Debt Discount Due to Issuance
Interest Expense, Total				12,000	11,000
Warrants Related to the 2018 Convertible Notes [Member]
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold		10.00%
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold		25.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares		$ 0.25
Warrants and Rights Outstanding, Term (Year)		10 years
The 2017 Convertible Notes [Member]
Long-term Debt, Gross				4,370,000		4,370,000
Debt Instrument, Unamortized Discount, Total				334,000		$ 362,000
Long-term Debt, Total				4,036,000
Debt Instrument, Interest Rate, Stated Percentage						6.00%
Debt Instrument, Term (Year)						5 years
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares							$ 0.333	$ 0.50
Proceeds from Convertible Debt
Increase in Unamortized Debt Discount Due to Issuance
Interest Expense, Total				92,000	80,000
The 2017 Convertible Notes [Member] | Maximum [Member]
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement						$ 5,000,000
The 2016 Convertible Notes [Member]
Long-term Debt, Gross				2,990,000		2,990,000
Debt Instrument, Unamortized Discount, Total				864,000		$ 997,000
Long-term Debt, Total				2,126,000
Debt Instrument, Interest Rate, Stated Percentage			6.00%
Debt Instrument, Term (Year)			5 years
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares			$ 0.25
Proceeds from Convertible Debt
Increase in Unamortized Debt Discount Due to Issuance
Interest Expense, Total				$ 177,000	$ 169,000
The 2016 Convertible Notes [Member] | Maximum [Member]
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement			$ 3,000,000

Note 5 - Senior Convertible N_4

Note 5 - Senior Convertible Notes and Warrants - Schedule of Senior Convertible Notes Outstanding (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Face value	$ 10,310,000
Notes issued	560,000
Face value	10,870,000
Debt discount	(1,900,000)
Debt discount issued	(16,000)
Amortization reported as interest	200,000	$ 165,000
Debt discount	(1,716,000)
Senior convertible notes (net)	9,154,000
The 2019 Convertible Notes [Member]
Face value	650,000
Notes issued	560,000
Face value	1,210,000
Debt discount	(3,000)
Debt discount issued	(16,000)
Amortization reported as interest	8,000
Debt discount	(11,000)
Senior convertible notes (net)	1,199,000
July 2018 Convertible Notes [Member]
Face value	1,675,000
Notes issued
Face value	1,675,000
Debt discount	(353,000)
Debt discount issued
Amortization reported as interest	20,000
Debt discount	(333,000)
Senior convertible notes (net)	1,342,000
The 2018 Convertible Notes [Member]
Face value	625,000
Notes issued
Face value	625,000
Debt discount	(185,000)
Debt discount issued
Amortization reported as interest	11,000
Debt discount	(174,000)
Senior convertible notes (net)	451,000
The 2017 Convertible Notes [Member]
Face value	4,370,000
Notes issued
Face value	4,370,000
Debt discount	(362,000)
Debt discount issued
Amortization reported as interest	28,000
Debt discount	(334,000)
Senior convertible notes (net)	4,036,000
The 2016 Convertible Notes [Member]
Face value	2,990,000
Notes issued
Face value	2,990,000
Debt discount	(997,000)
Debt discount issued
Amortization reported as interest	133,000
Debt discount	(864,000)
Senior convertible notes (net)	$ 2,126,000

Note 6 - Unsecured Subordinat_2

Note 6 - Unsecured Subordinated Promissory Notes (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Short-term Debt, Total	$ 425,000		$ 425,000
Unsecured Subordinated Promissory Notes [Member]
Short-term Debt, Total	$ 425,000		425,000
Debt Instrument, Interest Rate, Stated Percentage	6.00%
Interest Expense, Debt, Total	$ 6,000	$ 1,000
Debt Instrument, Increase, Accrued Interest	$ 21,000		$ 15,000

Note 7 - Right to Use Buildin_2

Note 7 - Right to Use Building Asset (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Aug. 01, 2019	Jan. 01, 2019
Operating Lease, Liability, Total			$ 212,000
Lessee, Operating Lease, Discount Rate			6.00%
Operating Lease, Cost	$ 16,000
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year	49,000
Lessee, Operating Lease, Liability, to be Paid, Year Two	65,000
Lessee, Operating Lease, Liability, to be Paid, Year Three	64,000
Lessee, Operating Lease, Liability, to be Paid, Total	195,000
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	18,000
Office Building with Terminated Lease Obligation [Member]
Operating Lease, Liability, Total				$ 257,000
Lessee, Operating Lease, Discount Rate		6.00%
Operating Lease, Cost	$ 19,000

Note 8 - Software (Details Text

Note 8 - Software (Details Textual) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Capitalized Computer Software, Amortization	$ 4,000
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	3 years	3 years

Note 9 - Property and Equipme_3

Note 9 - Property and Equipment - Property and Equipment (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Office equipment	$ 199,000	$ 199,000
Shop equipment	132,000	132,000
Property and equipment (gross)	331,000	331,000
Less accumulated depreciation	(296,000)	(293,000)
Net property and equipment	$ 35,000	$ 38,000

Note 10 - Business Segments (De

Note 10 - Business Segments (Details Textual)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Number of Operating Segments	2	2

Note 10 - Business Segments - O

Note 10 - Business Segments - Operation by Segments (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Revenue	$ 3,000	$ 7,000
Margin	2,000	1,000
Total costs and expenses	418,000	875,000
Loss from operations	(416,000)	(874,000)
Non-operating expense	(337,000)	(274,000)
Net loss	(753,000)	(1,148,000)
Stock-based compensation	39,000	59,000
Depreciation and amortization	19,000	30,000
Assets	376,000	355,000	$ 251,000
Operating Segments [Member] | CURA Division [Member]
Revenue	3,000	7,000
Margin	2,000	1,000
Total costs and expenses	54,000	339,000
Loss from operations	(52,000)	(338,000)
Non-operating expense
Net loss	(52,000)	(338,000)
Stock-based compensation	23,000	8,000
Depreciation and amortization		6,000
Assets		9,000
Operating Segments [Member] | Aegis Division [Member]
Revenue
Margin
Total costs and expenses	65,000	169,000
Loss from operations	(65,000)	(169,000)
Non-operating expense
Net loss	(65,000)	(169,000)
Stock-based compensation	4,000	8,000
Depreciation and amortization	3,000	5,000
Assets	34,000	50,000
Corporate, Non-Segment [Member]
Revenue
Margin
Total costs and expenses	299,000	367,000
Loss from operations	(299,000)	(367,000)
Non-operating expense	(337,000)	(274,000)
Net loss	(636,000)	(641,000)
Stock-based compensation	12,000	43,000
Depreciation and amortization	16,000	19,000
Assets	$ 181,000	$ 296,000

Note 11 - Preferred and Commo_2

Note 11 - Preferred and Common Stock (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Common stock, shares authorized (in shares)	400,000,000		400,000,000
Common stock, par value (in dollars per share)	$ 0.01		$ 0.01
Preferred stock, shares authorized (in shares)	100,000,000		100,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.01		$ 0.01
Preferred Class A [Member]
Preferred stock, shares outstanding (in shares)	468,221		468,221
Preferred Stock, Shares Outstanding, Not Accruing Dividends (in shares)	8,709		8,709
Preferred Stock, Shares Outstanding, Accruing Dividends (in shares)	459,512
Dividends Payable	$ 2,759		$ 2,713,000
Preferred Stock, Liquidation Preference, Value	$ 2,759,000		$ 2,713,000
Preferred Stock, Liquidation Preference Per Share (in dollars per share)	$ 4
Preferred Class B [Member]
Preferred stock, shares outstanding (in shares)	67,500		67,500
Dividends Payable	$ 496,000		$ 488,000
Preferred Stock, Liquidation Preference Per Share (in dollars per share)	$ 5
Series C Preferred Stock [Member]
Preferred stock, shares outstanding (in shares)	15,687,500		15,687,500
Preferred Stock, Liquidation Preference, Value	$ 6,275,000		$ 6,275,000
Preferred Stock, Liquidation Preference Per Share (in dollars per share)			$ 0.40
Series C2 Preferred Stock [Member]
Preferred stock, shares outstanding (in shares)	24,500,000		24,500,000
Preferred Stock, Liquidation Preference, Value	$ 4,900,000		$ 4,900,000
Series C3 Preferred Stock [Member]
Preferred stock, shares outstanding (in shares)	3,238,000		3,238,000
The 2016 Convertible Notes [Member]
Stock Issued During Period, Shares, New Issues (in shares)	94,772
Shares Issued, Price Per Share (in dollars per share)	$ 0.25
The 2019 Convertible Notes [Member]
Stock Issued During Period, Shares, New Issues (in shares)	112,500
The 2016 and 2017 Convertible Note [Member]
Stock Issued During Period, Shares, New Issues (in shares)		35,996
Shares Issued, Price Per Share (in dollars per share)		$ 0.25

Note 12 - Stock Options (Detail

Note 12 - Stock Options (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2016	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	2,100,000
Share-based Payment Arrangement, Expense	$ 39,000	$ 59,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total	$ 234,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	1 year
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)	$ 0.10
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$ 42,000	$ 4,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in shares)	404,250
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period (in shares)	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in shares)	0	0
Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share)	$ 0.07
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share)	$ 1.58
Stock Option Plan 2016 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)			3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)	111,250
Stock Option Plan 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)				3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)	352,500
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum	10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date	110.00%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	2,100,000	0

Note 12 - Stock Options - Stock

Note 12 - Stock Options - Stock Options Valuation Assumptions (Details)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Expected term (years) (Year)	6 years 109 days
Expected forfeiture rate	0.00%
Risk-free rate	1.30%
Volatility	179.00%
Dividend yield	0.00%

Note 12 - Stock Options - Share

Note 12 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Outstanding shares (in shares)	10,740,500
Outstanding - weighted average exercise price (in dollars per share)	$ 0.50
Outstanding - weighted average remaining contractual term (Year)	3 years 182 days		2 years 219 days
Outstanding - aggregate intrinsic value	$ 21,000
Shares, granted (in shares)	2,100,000
Weighted average exercise price, granted (in dollars per share)	$ 0.10
Shares, exercised (in shares)	0	0
Weighted average exercise price, exercised (in dollars per share)
Shares, canceled or expired (in shares)	(404,250)
Weighted average exercise price, canceled or expired (in dollars per share)	$ 0.68
Outstanding shares (in shares)	12,436,250		10,740,500
outstanding - weighted average exercise price (in dollars per share)	$ 0.43		$ 0.50
Shares, exercisable (in shares)	7,608,250
Weighted average exercise price, exercisable (in dollars per share)	$ 0.53
Exercisable- weighted average remaining contractual term (Year)	2 years 146 days
Exercisable-aggregate intrinsic value	$ 5,000

Note 13 - Warrants (Details Tex

Note 13 - Warrants (Details Textual) - shares	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Class of Warrant or Right, Outstanding (in shares)	7,631,707	7,731,707
Warrants without Expiration Date, Outstanding (in shares)	743,500		743,500
Warrants without Expiration Date, Exercisable (in shares)	118,500		118,500
Warrants Not Determined, Exercise Price [Member]
Class of Warrant or Right, Outstanding (in shares)	1,750,000		1,750,000

Note 14 - Warrants - Summary of

Note 14 - Warrants - Summary of Outstanding Warrants (Details) - USD ($)		3 Months Ended	12 Months Ended
		Mar. 31, 2020	Dec. 31, 2019
Shares outstanding (in shares)		7,731,707
Outstanding, weighted average exercise price (in dollars per share)	[1]	$ 0.45
Outstanding, weighted average remaining contractual term (Year)	[2]	6 years 36 days	6 years 73 days
Outstanding, aggregate intrinsic value		$ 41,000	$ 33,000
Shares granted (in shares)
Granted, weighted average exercise price (in dollars per share)
Shares exercised (in shares)
Exercised, weighted average exercise price (in dollars per share)
Shares canceled or expired (in shares)		(100,000)
Canceled or expired, weighted average exercise price (in dollars per share)		$ 2.50
Shares outstanding (in shares)		7,631,707	7,731,707
Outstanding, weighted average exercise price (in dollars per share)	[1]	$ 0.42	$ 0.45
Shares exercisable (in shares)		7,006,707
Exercisable, weighted average exercise price (in dollars per share)		$ 0.46
Exercisable, weighted average remaining contractual term (Year)	[3]	6 years 36 days
Exercisable, aggregate intrinsic value		$ 40,000
[1]	The weighted average exercise price for warrants outstanding as of March 31, 2020 and 2019 excludes 1,750,000 warrants in each period with no determined exercise price.
[2]	The weighted average remaining contractual term for warrants outstanding as of March 31, 2020 and 2019 excludes 743,500 warrants with no expiration date.
[3]	The weighted average remaining contractual term for warrants exercisable as of March 31, 2020, and 2019 excludes 118,500 warrants with no expiration date.

Note 14 - Related Party Trans_2

Note 14 - Related Party Transactions (Details Textual)	3 Months Ended	12 Months Ended
	Mar. 31, 2020USD ($)shares	Dec. 31, 2019USD ($)shares
Short-term Debt, Total	$ 425,000	$ 425,000
Unsecured Subordinated Promissory Notes [Member]
Debt Instrument, Increase, Accrued Interest	21,000	15,000
Short-term Debt, Total	$ 425,000	$ 425,000
Debt Instrument, Interest Rate, Stated Percentage	6.00%
Six Members of the Board of Directors [Member] | Warrants Related to the Convertible Notes [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares	1,184,273	1,239,288
Six Members of the Board of Directors [Member] | Convertible Notes [Member]
Notes Payable, Related Parties	$ 2,363,000	$ 2,477,000
Debt Instrument, Convertible, Number of Equity Instruments	9,071,562	9,388,378
Debt Instrument, Increase, Accrued Interest	$ 161,000	$ 164,000
Affiliated Entity [Member] | Warrants Related to the Convertible Notes [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares	468,000	468,000
Debt Instrument, Increase, Accrued Interest	$ 109,000	$ 88,000
Affiliated Entity [Member] | Convertible Notes [Member]
Notes Payable, Related Parties	$ 1,670,000	$ 1,170,000
Debt Instrument, Convertible, Number of Equity Instruments	8,013,333	4,680,000
Chief Executive Officer [Member] | Unsecured Subordinated Promissory Notes [Member]
Debt Instrument, Increase, Accrued Interest	$ 20,000
Debt Instrument, Interest Rate, Stated Percentage	6.00%

Note 15 - Subsequent Events (De

Note 15 - Subsequent Events (Details Textual)	Apr. 20, 2020USD ($)	Apr. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2019
Stock Issued During Period, Shares, Conversion of Convertible Securities			$ 17,000	$ 8,000
The 2019 Convertible Notes [Member]
Debt Instrument, Convertible, Number of Equity Instruments					30,000
Subsequent Event [Member]
Proceeds from Paycheck Protection Program Under CARES Act	$ 227,700
Stock Issued During Period, Shares, Conversion of Convertible Securities		$ 123,074
Stock Issued During Period, Value, Conversion of Convertible Securities		$ 21,000
Subsequent Event [Member] | The 2019 Convertible Notes [Member]
Debt Instrument, Convertible, Number of Equity Instruments		37,500